[1]
S. Bhella, “Chimeric Antigen Receptor (CAR) T-cell Therapy in Multiple Myeloma: The Evolving Canadian Landscape”, Can Hematol Today, vol. 2, no. 3, pp. 33–38, Nov. 2023.